Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,281 | 375 | 99.8% |
| Education | $12.15 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,613 | 75 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $904.21 | 60 | $0 (2024) |
| Alkermes, Inc. | $663.43 | 37 | $0 (2024) |
| ITI, Inc. | $614.56 | 25 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $543.33 | 30 | $0 (2024) |
| Lundbeck LLC | $480.59 | 27 | $0 (2024) |
| Corium, LLC | $464.80 | 25 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $348.92 | 16 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $263.07 | 11 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $198.06 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,365 | 118 | ABBVIE INC. ($416.12) |
| 2023 | $2,169 | 119 | ABBVIE INC. ($377.24) |
| 2022 | $2,171 | 112 | ABBVIE INC. ($819.64) |
| 2021 | $588.63 | 27 | Takeda Pharmaceuticals U.S.A., Inc. ($208.27) |
All Payment Transactions
376 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Neuroscience | ||||||
| 12/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: CNS | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neuropsychiatry | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 182 | $34,250 | $9,638 |
| 2022 | 2 | 37 | 179 | $37,327 | $9,269 |
| 2021 | 2 | 42 | 264 | $79,532 | $14,112 |
| 2020 | 4 | 127 | 324 | $69,251 | $16,414 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 95 | $19,000 | $6,099 | 32.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 25 | 87 | $15,250 | $3,539 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 96 | $22,350 | $6,001 | 26.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 17 | 83 | $14,977 | $3,268 | 21.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 135 | $47,250 | $8,877 | 18.8% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 20 | 129 | $32,282 | $5,235 | 16.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 204 | $45,420 | $10,523 | 23.2% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 19 | 93 | $18,261 | $4,069 | 22.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 11 | 11 | $3,545 | $1,032 | 29.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 16 | $2,025 | $790.91 | 39.1% |
About Eniayo Egberongbe
Eniayo Egberongbe is a Registered Nurse healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2017. The National Provider Identifier (NPI) number assigned to this provider is 1295263515.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eniayo Egberongbe has received a total of $7,294 in payments from pharmaceutical and medical device companies, with $2,365 received in 2024. These payments were reported across 376 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,281).
As a Medicare-enrolled provider, Egberongbe has provided services to 257 Medicare beneficiaries, totaling 949 services with total Medicare billing of $49,433. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health, Family
- Location Cranston, RI
- Active Since 05/31/2017
- Last Updated 06/29/2021
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295263515
Products in Payments
- VRAYLAR (Drug) $1,613
- REXULTI (Drug) $945.18
- CAPLYTA (Drug) $812.62
- ARISTADA (Drug) $663.43
- AUSTEDO (Drug) $375.50
- Austedo XR (Drug) $328.81
- TRINTELLIX (Drug) $310.47
- INGREZZA (Drug) $263.07
- Azstarys (Drug) $252.23
- AZSTARYS (Drug) $212.57
- UZEDY (Drug) $199.90
- JORNAY PM (Drug) $192.81
- Auvelity (Drug) $182.30
- FANAPT (Drug) $106.57
- LATUDA (Drug) $97.05
- SPRAVATO (Drug) $87.33
- QUVIVIQ (Drug) $76.24
- Qelbree (Drug) $70.57
- ZURZUVAE (Drug) $68.09
- COBENFY (Drug) $58.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Cranston
Aliza Lurie
Registered Nurse — Payments: $2,621
Taramarie Piecyk, Rn, Np, RN, NP
Registered Nurse — Payments: $1,880
Janet Spinelli
Registered Nurse — Payments: $665.98
Courtney Mulroy
Registered Nurse — Payments: $629.57
Coretta Antwi, Np, NP
Registered Nurse — Payments: $128.65
Stacy Mensah, Np, NP
Registered Nurse — Payments: $120.49